S&CO Inc’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$918K	Buy	25,255 +5,000	+25%	+$182K	0.06%	146
2025 Q1	$733K	Hold	20,255	–	–	0.05%	159
2024 Q4	$852K	Hold	20,255	–	–	0.06%	144
2024 Q3	$1.13M	Hold	20,255	–	–	0.07%	135
2024 Q2	$832K	Buy	+20,255	New	+$832K	0.06%	149